Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23417)

• Formulation Name: Delafloxacin Meglumine 300 mg For Injection
• Company: Melinta Therapeutics

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
ABT-492	(DMJFD2I)	Bacterial infection	1A00-1C4Z	Phase 3

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Cellulose microcrystalline	(E00698)	Not Available	Adsorbent; Suspending agent; Diluent
Crospovidone	(E00626)	Not Available	Disintegrant
Kyselina citronova	(E00014)	311	Acidulant; Antioxidant; Buffering agent; Complexing agent; Flavoring agent
Magnesium stearate	(E00208)	11177	lubricant
Povidone	(E00667)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Sodium bicarbonate	(E00424)	516892	Alkalizing agent; Diluent
Sodium phosphate monobasic monohydrate	(E00428)	516949	Buffering agent; Complexing agent